GLG Partners’s Pediatrix Medical MD Stock Holding History

GLG Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,500	Closed	-$896K	–	468
2015 Q4	$896K	Buy	+12,500	New	+$925K	0.03%	325

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GLG Partners's MD Position: Q1 2016 in Review

GLG Partners sold out of Pediatrix Medical (MD) in Q1 2016, closing a stake of 12,500 shares — an estimated $896K sold.

GLG Partners first reported a position in MD in Q4 2015 and held it in 1 quarter. The position peaked at $896K in Q4 2015. 382 funds tracked by Wall St. Rank hold MD as of Q1 2016.

GLG Partners reported no remaining Pediatrix Medical position as of Q1 2016 after selling out during the quarter.
GLG Partners sold 12,500 Pediatrix Medical shares in Q1 2016, an estimated $896K.
GLG Partners first reported a position in Pediatrix Medical in Q4 2015 and held it in 1 quarter.
GLG Partners's Pediatrix Medical position peaked at $896K in Q4 2015.
382 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2016.

Based on GLG Partners's 13F filing for Q1 2016, filed 16 May 2016.